Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Visilizumab [USAN:INN]
RN: 219716-33-3
UNII: H18SKU3289

Note

  • A humanized non-FcR-binding anti-CD3 antibody for treatment of steroid-refractory acute graft-versus-host disease.

Molecular Formula

  • Unspecified
 

Classification Codes

  • Immunologic Factors
  • Treatment of Organ Transplantation Rejection and Other T Lymphocyte-Mediated Diseases and Disorders, Including Autoimmune Diseases (Monoclonal Antibody)
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Visilizumab
  • Visilizumab [USAN:INN]

Synonyms

  • HuM 291
  • HuM291
  • Immunoglobulin G2 (human-mouse monoclonal HuM291 gamma2-chain anti-human antigen CD3), disulfide with human-mouse monoclonal HuM291 kappa-chain, dimer. Molecular weight is approximately 150,000 daltons
  • Immunoglobulin G2, anti-(human CD3 (antigen)) (human-mouse monoclonal HuM291 gamma2-chain), disulfide with human-mouse monoclonal HuM291 kappa-chain, dimer
  • Nuvion
  • UNII-H18SKU3289
  • Visilizumab

Systematic Name

  • Immunoglubulin, anti-(human CD3 (antigen)) (human-mouse monoclonal HuM291 gamma2-chain), disulfide with human-mouse monoclonal HuM291 kappa-chain , dimer

Registry Numbers

CAS Registry Number

  • 219716-33-3

FDA UNII

  • H18SKU3289

Other Registry Number

  • 339300-54-8

System Generated Number

  • 0219716333